Breaking News Bar

Business News and Information

Annovis Bio resumes Alzheimer's study delayed by Covid-19 outbreak

The company is testing its experimental therapy in patients with early-onset Alzheimer's.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear